510(k) Report

510(k) · Cleared

Cleared

For Sure One Step Buprenorphine Test Strip

K042990510(k) TraditionalCleared May 10, 2005193-day reviewClass II21 CFR 862.3650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tianjin New Bay Bioresearch Co., Ltd. · DJG Enzyme Immunoassay, Opiates

Cleared on May 10, 2005 as substantially equivalent to K040316 (Microgenics Corp., 2004) after a 193-day review. Its family tree reaches back 2 generations to 2000. 1 later device descends from it.

Decided
May 10, 2005
Review
193 days
Class
Class II
Product code
DJG
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K001178 (2000). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2013: 1 descendant clearedK001178 · Cedia Dau 6-Acetylmorphine Assay · Microgenics Corp. · 2000K040316 · Cedia Buprenorphine Assay · Microgenics Corp. · 2004200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K040316 · Cedia Buprenorphine Assay · Microgenics Corp. · 2004K001178 · Cedia Dau 6-Acetylmorphine Assay · Microgenics Corp. · 20000
  1. Root · 2 generations backK001178 Cedia Dau 6-Acetylmorphine AssayMicrogenics Corp. · 2000
  2. 1 generation backK040316 Cedia Buprenorphine AssayMicrogenics Corp. · 2004
  3. This deviceK042990 For Sure One Step Buprenorphine Test StripTianjin New Bay Bioresearch Co., Ltd. · 2005
  4. Descendant · cites it directly · 0 of its ownK122064 Forsure One Step Buprenorphine Cup Test DeviceTianjin New Bay Bioresearch Co., Ltd. · 2013

Most influential descendants

Showing 1 of 1 · See all
  • K122064Forsure One Step Buprenorphine Cup Test DeviceTianjin New Bay Bioresearch Co., Ltd. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K001178Cedia Dau 6-Acetylmorphine AssayMicrogenics Corp.2000—
−1K040316Cedia Buprenorphine AssayMicrogenics Corp.2004—
0 (this device)K042990For Sure One Step Buprenorphine Test StripTianjin New Bay Bioresearch Co., Ltd.2005—
+1K122064Forsure One Step Buprenorphine Cup Test DeviceTianjin New Bay Bioresearch Co., Ltd.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
FIG. 1 — Lineage of K042990, 2000–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DJG device

  1. #1 K232659 Dochek® Multi-Drug Urine Test Cup Rx, Dochek®…score 17.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040316Cedia Buprenorphine Assay
Summary page 1
…tory Class: Class II Predicate Devices: For Sure One Step Buprenorphine Strip Test Device is substantially equivalent to The CEDIAV Buprenorphine Assay cleared by FDA (K0403 16), and GC/MS for its stated intended use. Device Description: The For Sure One Step Buprenorphine Strip Test Devi…
Microgenics Corp.2004—
*—GC/MS
Named without a submission number
—

Also cleared against K040316: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K122064Forsure One Step Buprenorphine Cup Test DeviceTianjin New Bay Bioresearch Co., Ltd.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 4.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K122064 (Tianjin New Bay Bioresearch Co., Ltd., 2013) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K040316.

How does its category compare?

All DJG devices

DJG Enzyme Immunoassay, Opiates: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DJG

3in 2025

2007: 22008: 22009: 22010: 62011: 62012: 52013: 52014: 92015: 122016: 22017: 42018: 52019: 32020: 52021: 32022: 22023: 102024: 52025: 32026 (partial year): 3
2007high 12 (2015) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJG

31in 2025

2010: 187 days median2011: 233 days median2012: 95 days median2013: 60 days median2014: 62 days median2015: 141 days median2017: 101 days median2018: 134 days median2019: 235 days median2020: 30 days median2021: 422 days median2023: 140 days median2024: 150 days median2025: 31 days median2026 (partial year): 157 days median
2007high 422 (2021) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJG

2in 2025

2011: 12019: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJG

1in 2025

2011: 42012: 12013: 42015: 32016: 22017: 12018: 12021: 22022: 12024: 32025: 1
2007high 4 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20092—00
2010618700
2011623314
201259501
201356004
201496200
20151214103
20162—02
2017410101
2018513401
2019323510
202053000
2021342202
20222—01
20231014000
2024515003
202533121
202631570—

What is it indicated for?

For Sure One Step Buprenorphine Strip Test Device is an immunochromatographic immunoassay for qualitative determination of the presence of buprenorphine in human urine at cutoff concentration of 10 ng/ml. The assay provides a simple and rapid analytical screening procedure to detect buprenorphine in human urine.

The assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas chromatography /mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical and professional judgment should be applied to any drug of abuse test results particularly when preliminary results are used.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042990: For Sure One Step Buprenorphine Test Strip.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K042990

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026